IPMABI Trademark

Trademark Overview

On Wednesday, May 20, 2020, a trademark application was filed for IPMABI with the United States Patent and Trademark Office. The USPTO has given the IPMABI trademark a serial number of 88925259. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2023. This trademark is owned by Genzyme Corporation. The IPMABI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
ipmabi

General Information

Serial Number88925259
Word MarkIPMABI
Filing DateWednesday, May 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare blood disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, December 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU EXTENSION 5 GRANTED
Tuesday, April 4, 2023SOU EXTENSION 5 FILED
Wednesday, April 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2022SOU EXTENSION 4 GRANTED
Friday, September 30, 2022SOU EXTENSION 4 FILED
Friday, September 30, 2022SOU TEAS EXTENSION RECEIVED
Saturday, April 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2022SOU EXTENSION 3 GRANTED
Thursday, March 31, 2022SOU EXTENSION 3 FILED
Thursday, March 31, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 27, 2021SOU EXTENSION 2 FILED
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2021SOU EXTENSION 1 GRANTED
Monday, April 5, 2021SOU EXTENSION 1 FILED
Monday, April 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020ASSIGNED TO EXAMINER
Friday, June 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 23, 2020NEW APPLICATION ENTERED

Related Keywords

ipmabi pharmaceutical treatment diseases preparations prevention infectious disorders namely viral infections